8-K: James River Group Reports Fourth Quarter 2024 Results, Marked by Strategic Shifts and a Net Loss

James River Group's Q4 2024 results reveal a net loss, influenced by strategic actions including reinsurance agreements and preferred share amendments, alongside growth in the E&S segment.

Summary

• James River Group Holdings reported a net loss of $94.041 million for Q4 2024, or $2.28 per diluted share, compared to a net loss of $152.780 million, or $3.43 per diluted share, for the same period in 2023.
• Adjusted net operating loss was $40.8 million ($0.99 per diluted share) for Q4 2024, compared to an adjusted net operating income of $12.442 million ($0.33 per diluted share) for Q4 2023.
• The decrease was largely due to a $52.8 million consideration paid for an Excess and Surplus Lines (E&S) adverse development reinsurance contract with Cavello Bay Reinsurance Limited.
• A $27 million deemed dividend from the November 2024 amendment to the Series A Preferred Shares also negatively impacted net loss from continuing operations.
• Gross written premium for the E&S segment exceeded $1.0 billion for the second consecutive year, showing a slight increase from the prior year.
• The company completed strategic actions including the sale of JRG Reinsurance Company Ltd., entering into a $160.0 million combined loss portfolio transfer and adverse development cover for its E&S business, and amending the Series A Preferred Shares.
• Full year 2024 net investment income increased 10.8% compared to 2023.
• The Specialty Admitted Insurance segment's combined ratio was 92.2% for 2024, compared to 95.9% for 2023, with underwriting profit growing 68.6% compared to the prior year.
• Shareholders' equity per share decreased sequentially from $14.02 at September 30, 2024, to $10.10 due to the net loss from continuing operations and an increase in common shares outstanding.
• The Board of Directors declared a cash dividend of $0.01 per common share, payable on March 31, 2025, to shareholders of record on March 10, 2025.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the reported net loss and adjusted operating loss. However, strategic actions taken to de-risk the company and the positive outlook for the E&S market provide some optimism.

Positives

• E&S segment gross written premium exceeded $1.0 billion for the second consecutive year.
• Full year 2024 net investment income increased 10.8% compared to 2023.
• Specialty Admitted Insurance segment combined ratio improved to 92.2% for 2024, with underwriting profit growing 68.6% compared to the prior year.
• The company completed strategic actions to strengthen its balance sheet, including the sale of JRG Reinsurance Company Ltd. and entering into a $160.0 million combined loss portfolio transfer and adverse development cover for its E&S business.
• The company had its highest levels of both new and renewal annual submission growth in five years, and positive renewal rate change of 9.0% for 2024.

Negatives

• The company reported a net loss of $94.041 million for Q4 2024.
• Adjusted net operating loss was $40.8 million for Q4 2024.
• Shareholders' equity per share decreased sequentially from $14.02 at September 30, 2024, to $10.10.
• The consolidated expense ratio increased to 43.7% for Q4 2024, primarily due to the $52.8 million consideration paid for the E&S Top Up ADC.

Risks

• The inherent uncertainty of estimating reserves and the possibility that incurred losses may be greater than loss and loss adjustment expense reserves.
• Downgrades in the financial strength rating or outlook of regulated insurance subsidiaries impacting the ability to attract and retain insurance business.
• Potential loss of key members of the management team or key employees and the ability to attract and retain personnel.
• Adverse economic factors resulting in the sale of fewer policies than expected or an increase in the frequency or severity of claims.
• Exposure to credit risk, interest rate risk, and other market risks in the investment portfolio.

Future Outlook

The company believes that 2025 will provide significant opportunities to responsibly grow while taking advantage of the attractive rate environment in the E&S market.

Management Comments

• Frank D'Orazio, the Company's Chief Executive Officer, commented, 2024 was a costly but transformational year for James River.
• We have meaningfully de-risked the organization and concluded an extensive strategic review, emerging with a renewed focus.
• The E&S market remains very healthy, and we believe that 2025 will provide significant opportunities to responsibly grow while taking advantage of the attractive rate environment.

Industry Context

The report highlights the 'very healthy' E&S market, suggesting James River is positioning itself to capitalize on favorable rate conditions, which aligns with broader industry trends of increasing rates in specialty lines.

Comparison to Industry Standards

• It's difficult to provide a precise comparison without knowing the specific composition of James River's E&S and Specialty Admitted portfolios.
• However, a combined ratio of 92.2% for the Specialty Admitted segment is generally competitive, as many well-run specialty insurers target combined ratios in the lowto mid-90s.
• Companies like RLI Corp. and W.R. Berkley often achieve combined ratios in this range.
• The E&S segment's performance is more challenging to benchmark without knowing the specific risks underwritten, but the focus on wholesale distribution is a common strategy in this market.

Management Changes

Stakeholder Impact

• Shareholders will receive a cash dividend of $0.01 per common share.
• Employees may be affected by the company's strategic shift and renewed focus.
• Customers in the E&S market may benefit from the company's focus on growth and attractive rates.

Next Steps

• The company will focus on responsibly growing and taking advantage of the attractive rate environment in the E&S market in 2025.
• James River will hold a conference call to discuss its fourth quarter results on March 4, 2025.
• The company will pay a cash dividend of $0.01 per common share on March 31, 2025.

Key Dates